RNS
HSTO

Robert N. Shapiro’s Histogen Inc. Common Stock HSTO Stock Holding History

Robert N. Shapiro’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-30
Closed -$49K – 809
2014
Q1 		$49K Buy
+30
New +$62.7K 0.01% 464

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Robert N. Shapiro's HSTO Position: Q2 2014 in Review

Robert N. Shapiro sold out of Histogen Inc. Common Stock (HSTO) in Q2 2014, closing a stake of 30 shares — an estimated $49K sold.

Robert N. Shapiro first reported a position in HSTO in Q1 2014 and held it in 1 quarter. The position peaked at $49K in Q1 2014. 38 funds tracked by Wall St. Rank hold HSTO as of Q2 2014.

  • Robert N. Shapiro reported no remaining Histogen Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Robert N. Shapiro sold 30 Histogen Inc. Common Stock shares in Q2 2014, an estimated $49K.
  • Robert N. Shapiro first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Robert N. Shapiro's Histogen Inc. Common Stock position peaked at $49K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2014.

Based on Robert N. Shapiro's 13F filing for Q2 2014, filed 11 Sep 2014.